Sofosbuvir–velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial
- Resource Type
- Article
- Authors
- Wei, Lai; Lim, Seng Gee; Xie, Qing; Văn, Kính Nguyen; Piratvisuth, Teerha; Huang, Yan; Wu, Shanming; Xu, Ming; Tang, Hong; Cheng, Jun; Le Manh, Hung; Gao, Yanhang; Mou, Zhuangbo; Sobhonslidsuk, Abhasnee; Dou, Xiaguang; Thongsawat, Satawat; Nan, Yuemin; Tan, Chee Kiat; Ning, Qin; Tee, Hoi Poh; Mao, Yimin; Stamm, Luisa M; Lu, Sophia; Dvory-Sobol, Hadas; Mo, Hongmei; Brainard, Diana M; Yang, Yong-Feng; Dao, Long; Wang, Gui-Qiang; Tanwandee, Tawesak; Hu, Peng; Tangkijvanich, Pisit; Zhang, Lunli; Gao, Zhi Liang; Lin, Feng; Le, Thi Tuyet Phuong; Shang, Jia; Gong, Guozhong; Li, Jun; Su, Minghua; Duan, Zhongping; Mohamed, Rosmawati; Hou, Jin Lin; Jia, Jidong
- Source
- In The Lancet Gastroenterology & Hepatology February 2019 4(2):127-134
- Subject
- Primary Research
Articles
- Language
- ISSN
- 2468-1253